Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Lorch

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
The Thoracic and Cardiovascular Surgeon|March 3, 2012
The role of residual tumor resection in the management of nonseminomatous germ cell cancer of testicular originJoachim Schirren, Stephan Trainer, Michael Eberlein, et al.
Current Opinion in Urology|March 20, 2021
Renal cell carcinoma pathology in 2021: 'new need for renal cancer immune profiling'Bettina Sobottka, Anja Lorch, Karina Silina, et al.
The Journal of Urology|May 21, 2010
High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumorsAnja Lorch, Oliver Rick, Thomas Wündisch, et al.
Journal of Clinical Nursing|January 30, 2024
Adoption of evidence-based end-of-life and bereavement support to families in cancer care: A contextual analysis study with health professionalsMarco Riguzzi, Qëndresa Thaqi, Simon Peng-Keller, et al.
BMC Health Services Research|February 2, 2024
End-of-life and bereavement support to families in cancer care: a cross-sectional survey with bereaved family membersQëndresa Thaqi, Marco Riguzzi, David Blum, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|April 16, 2024
Contextual determinants of guideline-based family support during end-of-life cancer care and subsequent bereavement care: A cross-sectional survey of registered nursesMarco Riguzzi, Qëndresa Thaqi, Anja Lorch, et al.
Frontiers in Oncology|September 16, 2024
PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussionTämer El Saadany, Anja Lorch, Matthew I Milowsky, et al.
Urologic Oncology|November 1, 2025
Improved quality of care for testicular germ cell cancer patients by the implementation of an interdisciplinary testis cancer clinicNico C Grossmann, Luca Funk, Christian D Fankhauser, et al.
Journal of Cancer Research and Clinical Oncology|November 15, 2014
First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international databaseChristoph Oing, Anja Lorch, Carsten Bokemeyer, et al.
European Urology|June 19, 2013
Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit?Günter Niegisch, Anja Lorch, Michael J Droller, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
The Thoracic and Cardiovascular Surgeon|March 3, 2012
The role of residual tumor resection in the management of nonseminomatous germ cell cancer of testicular originJoachim Schirren, Stephan Trainer, Michael Eberlein, et al.
Current Opinion in Urology|March 20, 2021
Renal cell carcinoma pathology in 2021: 'new need for renal cancer immune profiling'Bettina Sobottka, Anja Lorch, Karina Silina, et al.
The Journal of Urology|May 21, 2010
High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumorsAnja Lorch, Oliver Rick, Thomas Wündisch, et al.
Journal of Clinical Nursing|January 30, 2024
Adoption of evidence-based end-of-life and bereavement support to families in cancer care: A contextual analysis study with health professionalsMarco Riguzzi, Qëndresa Thaqi, Simon Peng-Keller, et al.
BMC Health Services Research|February 2, 2024
End-of-life and bereavement support to families in cancer care: a cross-sectional survey with bereaved family membersQëndresa Thaqi, Marco Riguzzi, David Blum, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|April 16, 2024
Contextual determinants of guideline-based family support during end-of-life cancer care and subsequent bereavement care: A cross-sectional survey of registered nursesMarco Riguzzi, Qëndresa Thaqi, Anja Lorch, et al.
Frontiers in Oncology|September 16, 2024
PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussionTämer El Saadany, Anja Lorch, Matthew I Milowsky, et al.
Urologic Oncology|November 1, 2025
Improved quality of care for testicular germ cell cancer patients by the implementation of an interdisciplinary testis cancer clinicNico C Grossmann, Luca Funk, Christian D Fankhauser, et al.
Journal of Cancer Research and Clinical Oncology|November 15, 2014
First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international databaseChristoph Oing, Anja Lorch, Carsten Bokemeyer, et al.
European Urology|June 19, 2013
Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit?Günter Niegisch, Anja Lorch, Michael J Droller, et al.
Pageof 8